Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × durvalumab × Clear all

Phase

Phase 2 40 Phase 1/2 6 Phase NA 5 Phase 1 4 Phase 4 1

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Metformin 13 Drug Therapy 11 Cytarabine 11 Cyclophosphamide 11 Dexamethasone 10 Cisplatin 10 Oxaliplatin 8 Carboplatin 8 icotinib 7 Sodium Chloride 7 Radiotherapy 7 Paclitaxel 7 Fluorouracil 7 Docetaxel 7 ulipristal acetate 6 Vincristine 6 Idarubicin 6 Granulocyte Colony-Stimulating Factor 6 Gemcitabine 6 Dexmedetomidine 6 entecavir 5 Thalidomide 5 Surgical Procedures, Operative 5 Sorafenib 5 S 1 (combination) 5 Propranolol 5 Pemetrexed 5 Methotrexate 5 Leuprolide 5 Endostatins 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04613284 2020-11-03

RELIEF

Shanghai Chest Hospital

Phase 4 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡